# Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia

> **NCT02459938** · PHASE1 · COMPLETED · sponsor: **Zosano Pharma Corporation** · enrollment: 16 (actual)

## Conditions studied

- Hypoglycemia

## Interventions

- **DRUG:** Glucagon (ZP-Glucagon)
- **DRUG:** Glucagon (GlucaGen)

## Key facts

- **NCT ID:** NCT02459938
- **Lead sponsor:** Zosano Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02459938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02459938, "Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02459938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*